Extracellular vesicles from alternatively activated macrophages remodel the injured hepatic niche and promote repair
Alternatively activated macrophages (AAMs) are in clinical development for acute liver injury, but their mechanisms of action remain incompletely understood. AAM therapy remodels the injured hepatic niche, promoting reparative macrophage states, suppressing inflammatory myeloid programmes and restoring hepatocyte metabolic and biosynthetic programmes. We identify extracellular vesicles released…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.